KYTX
Kyverna Therapeutics, Inc.
$9.68
+0.52 (+5.68%)
At close · Jul 7
Market Cap
$588.50M
Shares
60,795,212
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-02 | 2026-05-27 | |
| 8-K | 2026-05-18 | 2026-05-14 | |
| 8-K | 2026-05-12 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-05-04 | — | |
| 8-K | 2026-04-22 | 2026-04-21 | |
| 8-K | 2026-04-22 | — | |
| 8-K | 2026-04-20 | — | |
| DEF 14A | 2026-04-13 | 2026-05-27 | |
| 8-K | 2026-03-26 | — | |
| 10-K | 2026-03-26 | 2025-12-31 | |
| 8-K | 2026-02-24 | — | |
| 8-K | 2026-02-03 | 2026-01-29 | |
| 8-K | 2026-01-12 | 2026-01-08 | |
| 8-K | 2025-12-18 | 2025-12-17 | |
| 8-K | 2025-12-15 | — | |
| 8-K | 2025-12-15 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-11-12 | — | |
| 8-K | 2025-11-03 | 2025-11-02 | |
| 8-K | 2025-10-29 | — | |
| 8-K | 2025-10-29 | — | |
| 8-K | 2025-09-25 | 2025-09-19 | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-12 | — | |
| 8-K | 2025-06-30 | — | |
| 8-K | 2025-06-03 | 2025-05-29 | |
| 8-K | 2025-05-13 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| DEF 14A | 2025-04-14 | 2025-05-29 | |
| 8-K | 2025-03-27 | — | |
| 10-K | 2025-03-27 | 2024-12-31 | |
| 8-K | 2025-03-27 | — | |
| 8-K | 2025-01-21 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-11-26 | — | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-11-13 | 2024-11-08 | |
| 8-K | 2024-10-21 | 2024-10-20 | |
| 8-K | 2024-09-16 | 2024-09-13 | |
| 8-K | 2024-08-12 | — | |
| 10-Q | 2024-08-12 | 2024-06-30 | |
| 8-K | 2024-07-15 | — | |
| 8-K | 2024-06-14 | — | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| 8-K | 2024-05-14 | — | |
| 10-K | 2024-03-26 | 2023-12-31 | |
| 8-K | 2024-03-26 | — |
Showing 1–50 of 51 filings